Tru Independence Asset Management 2, LLC Danaher Corp Transaction History

Tru Independence Asset Management 2, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$239.75 - $277.0 $776,790 - $897,480	3,240 New	3,240 $816,000
Q1 2022 Apr 27, 2022	SELL	$257.27 - $315.76 $170,055 - $208,717	-661 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$292.08 - $329.01 $292 - $329	1 Added 0.15%	661 $217,000
Q3 2021 Nov 05, 2021	BUY	$272.21 - $332.43 $179,658 - $219,403	660 New	660 $201,000
Q1 2021 May 19, 2021	SELL	$212.38 - $245.9 $116,809 - $135,245	-550 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$212.5 - $245.46 $116,875 - $135,003	550 New	550 $122,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Tru Independence Asset Management 2, LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence Asset Management 2, LLC with notifications on news.